Exploring Nursing Roles in Early Detection of Neurodegenerative Diseases through Biomarkers

Abstract

Background:Neurodegenerative diseases, including Alzheimer’s, Parkinson’s, and Huntington’s, represent a growing public health challenge due to their progressive nature and lack of curative treatments. Early detection through biomarkers, such as imaging, cerebrospinal fluid proteins, and blood-based markers, has emerged as a critical strategy to improve patient outcomes. Nurses, as frontline healthcare providers, play a pivotal role in implementing early detection strategies, yet their potential in leveraging biomarkers remains underexplored.

Aim:This paper aims to examine the evolving roles of nurses in early detection of neurodegenerative diseases through the utilization of biomarkers, highlighting their contributions to patient screening, education, and interdisciplinary care.

Methods:A systematic literature review was conducted using databases including PubMed, CINAHL, and Google Scholar. Studies were selected based on relevance to nursing roles in biomarker utilization and neurodegenerative disease management. Qualitative analysis identified current practices, barriers, and opportunities for nurses in this domain.

Results:Findings revealed that nurse-led biomarker screening programs significantly enhance early detection efforts. However, gaps in nursing education regarding biomarkers and limited access to advanced diagnostic tools were identified as major barriers. Collaborative approaches and specialized training programs were shown to improve outcomes and expand nursing contributions.

Conclusion:Nurses are integral to early detection of neurodegenerative diseases through biomarker application. Enhancing their education and fostering interprofessional collaboration are essential to optimizing care. Future research should focus on developing standardized frameworks to support nursing roles in this field.